145 related articles for article (PubMed ID: 21106031)
1. Clinical predictors of exacerbation frequency in chronic obstructive pulmonary disease.
Brusse-Keizer M; van der Palen J; van der Valk P; Hendrix R; Kerstjens H
Clin Respir J; 2011 Oct; 5(4):227-34. PubMed ID: 21106031
[TBL] [Abstract][Full Text] [Related]
2. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Paul EA; Bestall JC; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1418-22. PubMed ID: 9603117
[TBL] [Abstract][Full Text] [Related]
3. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
4. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
5. Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease.
Ansari K; Keaney N; Taylor I; Burns G; Farrow M
Postgrad Med J; 2012 Jul; 88(1041):372-6. PubMed ID: 22388793
[TBL] [Abstract][Full Text] [Related]
6. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
7. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
8. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
[TBL] [Abstract][Full Text] [Related]
9. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory changes, recovery and recurrence at COPD exacerbation.
Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
[TBL] [Abstract][Full Text] [Related]
11. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
Tomioka R; Kawayama T; Suetomo M; Kinoshita T; Tokunaga Y; Imaoka H; Matsunaga K; Okamoto M; Hoshino T
Int J Chron Obstruct Pulmon Dis; 2016; 11():207-16. PubMed ID: 26893552
[TBL] [Abstract][Full Text] [Related]
12. Quality of life measured by the St George's Respiratory Questionnaire and spirometry.
Weatherall M; Marsh S; Shirtcliffe P; Williams M; Travers J; Beasley R
Eur Respir J; 2009 May; 33(5):1025-30. PubMed ID: 19164350
[TBL] [Abstract][Full Text] [Related]
13. Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare.
Llor C; Molina J; Naberan K; Cots JM; Ros F; Miravitlles M;
Int J Clin Pract; 2008 Apr; 62(4):585-92. PubMed ID: 18266710
[TBL] [Abstract][Full Text] [Related]
14. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.
Hagedorn C; Kässner F; Banik N; Ntampakas P; Fielder K
Respir Med; 2013 Apr; 107(4):542-9. PubMed ID: 23337300
[TBL] [Abstract][Full Text] [Related]
15. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD.
Kuna P; Jenkins M; O'Brien CD; Fahy WA
Respir Med; 2012 Apr; 106(4):531-9. PubMed ID: 22197578
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of pulmonary rehabilitation in exercise capacity and quality of life in chronic obstructive pulmonary disease patients with and without global fat-free mass depletion.
Berton DC; Silveira L; Da Costa CC; De Souza RM; Winter CD; Zimermann Teixeira PJ
Arch Phys Med Rehabil; 2013 Aug; 94(8):1607-14. PubMed ID: 23416765
[TBL] [Abstract][Full Text] [Related]
17. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
[TBL] [Abstract][Full Text] [Related]
18. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.
Calverley PM; Sanchez-Toril F; McIvor A; Teichmann P; Bredenbroeker D; Fabbri LM
Am J Respir Crit Care Med; 2007 Jul; 176(2):154-61. PubMed ID: 17463412
[TBL] [Abstract][Full Text] [Related]
19. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
20. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study.
van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C
Am J Respir Crit Care Med; 2002 Nov; 166(10):1358-63. PubMed ID: 12406823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]